Drug patents: Pay-for-delay’s bad day in court
Los Angeles Times
The Supreme Court struck a blow for consumers Monday in a closely watched patent case, ruling that manufacturers of brand-name drugs don’t have the right to buy off generic-drug makers by giving them a share of their monopoly profits. The 5-3 ruling …
Apple’s ‘Rubber Banding’ patent valid: US Patent and Trademark Office
iTech Post
The patent war between Apple and Samsung goes on. This time Apple wins a round as the U.S. Patent and Trademark office validated the company’s “rubber banding” or bounce back patent, triggering a re-examination. The “rubber banding” patent, …
Patents: Obama declares war on the patent trolls
ElectronicsWeekly.com
The term patent troll is slang for a firm that buys up obvious patents that the US Patent and Trademark Office (USPTO) should never have granted in the first place. The troll then “asserts” these patents by threatening to sue businesses that infringe them.
Inventors from UAE fold away patents
The National
Three Emirati inventors have created folding mechanisms that will improve new generation of tablets and smartphones with flexible screens. Wasfi Alshdaifat, his wife Eida Almuhairbi, and Farah Qassab developed two designs and have taken the …
Gene Patents News
Editorial: Supreme Court wisdom on DNA
Chicago Tribune
That’s the foundation of our system of patents as well as copyrights. The principle is simple: Those who create something new should be allowed to profit from their creations. This compensates them for the unique value they have produced, while …
US Supreme Court Restricts Gene Patents…
IP Watch
… puts the US at odds with most other nations, which allow genes to be patented. But because other major nations grant narrower gene patents, the net effect of Myriad will be to shift the US position on gene patents closer to that of other nations.
US Supreme Court’s judgment on gene patents is neither ethical nor logical
Economic Times
Patents are reserved for inventions, not naturally occurring phenomena. On the other hand, the synthetic gene — in this case, a sequence of what is called “complementary DNA” (cDNA) that includes only those elements of the gene sequence that actually …
Myriad: End to Legal Battle over Patents – Analyst Blog
NASDAQ
While the apex court upheld Myriad’s patent claims on complementary DNA or cDNA, the other five claims from the company to cover isolated DNA were declared not eligible for patents by the U.S. Supreme Court. According to the Court, most of Myriad’s …


